[115]
Moreover, Apotex alleges that the prior art also evidences the fact that, by May of 1985, the importance of the stereochemical configuration requirements for the same chiral centre present in flumequine and ofloxacin was established in the field. Additionally, by September 30, 1985, the person skilled in the art would have also been aware of the fact that the (S)(-)-enantiomer of yet another tricyclic fluoroquinolone antibiotic, S-25930, exhibited higher antimicrobial activity relative to its (+)-enantiomer or racemate. (NOA, p. 3512 of AR)